DoW Bone Marrow Failure, Idea Development Award
About
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. Distinctive Features: This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI. Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
The DoW Bone Marrow Failure Idea Development Award (IDA) is a competitive grant program designed to support innovative research addressing bone marrow failure (BMF) diseases. This funding opportunity is ideal for both Established Investigators (EIs) and Early-Career Investigators (ECIs) who are developing novel, scientifically sound approaches to advance understanding and treatment of BMF conditions. The program specifically welcomes applications based on innovative ideas without requiring preliminary data, making it accessible to researchers with creative hypotheses and interpretable study designs. The award supports high-impact research that aligns with the Bone Marrow Failure Research Program's (BMFRP) vision of curing BMF diseases. Researchers should demonstrate strong scientific reasoning and the ability to generate meaningful results even without existing preliminary data. This is an excellent opportunity for investigators at various career stages to secure funding for groundbreaking BMF research. The program uses distinct review criteria tailored to applicant experience levels, ensuring fair evaluation. If you are conducting research in hematology, immunology, or related fields focused on bone marrow conditions, this award may provide crucial support for your innovative work.
Funding Facts
● Applications openDeadline
November 4, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-11-04
Grant Type
federal
Application Cycle
Annual (Deadline: November 4, 2026)
Best For
Established and Early-Career Investigators conducting bone marrow failure research
Frequently Asked Questions
Who is eligible for DoW Bone Marrow Failure, Idea Development Award?
The award is open to both Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers assess applications using distinct criteria tailored to each investigator category. For specific institutional affiliations, citizenship requirements, or additional eligibility details, please visit the official BMFRP website or contact the program directly.
How much funding does DoW Bone Marrow Failure, Idea Development Award provide?
Specific funding amounts are not currently listed. Award amounts may vary by funding cycle. For detailed information about budget limits and expected award sizes, please contact the Department of Defense (DoD) Bone Marrow Failure Research Program or visit their official website.
How do I apply for DoW Bone Marrow Failure, Idea Development Award?
Applications are submitted through the official DoD grant management system. Interested researchers should visit the BMFRP website for current application portals, submission requirements, and detailed instructions. The application deadline is November 4, 2026. Ensure your proposal clearly describes your innovative approach and demonstrates the ability to achieve interpretable results even without preliminary data.
What can DoW Bone Marrow Failure, Idea Development Award funding be used for?
Funding supports research projects developing innovative ideas and high-impact approaches to understand and treat bone marrow failure diseases. Research must be scientifically sound and aligned with BMFRP's vision. Projects should demonstrate feasibility without requiring preliminary data. Contact the program office for detailed guidance on allowable expenses and research scope.
Last updated: July 5, 2026